| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |